Watch and Wait: Lymphoma and CLL Patients
Date/Time:
June 24th, 2025
(4:00-5:00) PM EST
Location:
Online
Description:
Join Dr. Versha Banerji for an insightful session on the “Watch and Wait” approach for lymphoma and CLL patients. In this presentation, Dr. Banerji will discuss the rationale behind this strategy, how it helps manage lymphoma and CLL progression, and what patients can expect during this period. She will also cover key considerations for maintaining wellness and monitoring symptoms while under observation. Don’t miss this opportunity to gain valuable insights into living with lymphoma and CLL under a “Watch and Wait” plan.
Speaker:
Dr. Versha Banerji
Speaker Bio:
Dr. Versha Banerji MD FRCPC obtained her MD and residency training in Internal Medicine and Hematology at the University of Manitoba. She then completed a post-doctoral fellowship in translational research at the Harvard Cancer Centre/ Dana-Farber Cancer Institute and Broad Institute of MIT. She is a Senior Scientist at the Paul Albrechtsen CancerCare Manitoba Research Institute, Associate Professor at the University of Manitoba, and a Clinician-Scientist at CancerCare Manitoba. She is the inaugural Director of The Chronic Lymphocytic Leukemia, Clinical Care, Education and Translational Research Unit at the University of Manitoba and CCMB and leads clinical trials and population-based treatment studies locally. She manages a multi-disciplinary research team in clinical, fundamental and translational research. Her own laboratory is evaluating novel therapeutics and the impact on mitochondrial function and metabolism. She is also an inaugural awardee of the University of Manitoba Ignite Grant securing over 2.8 Million dollars in funding from University, philanthropic, government and industry partners over the next 3 years.
